Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition - ScienceDirect
Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008 | Infectious Agents and Cancer | Full Text
IJMS | Free Full-Text | The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies
Sustained elevation of Epstein–Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma | British Journal of Cancer
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies | Journal of Neuroinflammation | Full Text
Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus - ScienceDirect
Epstein-Barr Virus (EBV) Antibodies Blood Test - DoveMed
Cancers | Free Full-Text | Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Identification of anti-Epstein-Barr virus (EBV) antibody signature in EBV-associated gastric carcinoma | Gastric Cancer
J Neurol Res
Epstein-Barr Virus Laboratory Testing | CDC
VIDAS EBV panel, diagnosis of Mononucleosis | bioMérieux Clinical Diagnostics
Pathogens | Free Full-Text | Investigation of Long COVID Prevalence and Its Relationship to Epstein-Barr Virus Reactivation
Frontiers | EBV-associated diseases: Current therapeutics and emerging technologies
Evidence of recent Epstein-Barr virus reactivation in individuals experiencing Long COVID | medRxiv